Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls.
about
Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findingsCigarette smoking and cognitive function in Chinese male schizophrenia: a case-control studynAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.Smoking, Genetics and Schizophrenia: Evidence for Self Medication.Clinical characteristics of heavy and non-heavy smokers with schizophrenia.Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder.Higher nicotine levels in schizophrenia compared with controls after smoking a single cigaretteNicotine usage is associated with elevated processing speed, spatial working memory, and visual learning performance in youth at ultrahigh-risk for psychosis.Investigation of cigarette smoking among male schizophrenia patients.Correlates and prevalence of menthol cigarette use among adults with serious mental illness.Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.Long term effects of smoking cessation in hospitalized schizophrenia patients.Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective.Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.Smoking topography and outcome expectancies among individuals with schizotypy.Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors.Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia.Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controlsEffectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.Nicotine self-administration reverses cognitive deficits in a rat model for schizophrenia.Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia.Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study.Smoking reduction and quality of life in chronic patients with schizophrenia in a Chinese population--A pilot study.Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study.Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach.Is smoking linked to positive symptoms in acutely ill psychiatric patients?Attenuated Positive Psychotic Symptoms in Relation to Cigarette Smoking in a Nonclinical Population.
P2860
Q24289498-AAA0451F-DD71-4F4B-B524-A7DC11200E18Q28730147-65F792AE-CF40-47A8-926B-C98B52228468Q30362464-C67BFC60-56E0-4AA3-BB0F-0C993EC97520Q30435496-BF53D3B1-ED17-4A06-BFE9-463AFA65E1A8Q30463995-ED5EB64A-AD88-41F8-95DC-35CE36D2C7A6Q30473410-9789C393-EE78-4307-8A31-3336CB15BBDDQ30491841-4DE8EEAE-4BAB-46C4-8A07-74B28A6AE24FQ33775576-97C5DC6F-D8AA-4C7C-9E48-C8245E4CE84FQ33811740-6C1040DC-9FAD-4CAA-AD11-CE9AFFB2B7B3Q34023532-63164058-7802-4BA0-8991-ABB46B2F253FQ34615823-524C46BC-F025-4490-A579-F6C2D3FF5219Q34970938-88A1AD34-4C3F-4076-938B-62565D7D2A37Q35127258-C4C3968A-8C7A-4DEF-A60C-738F0C9EC4B7Q35880018-D5560481-0B66-48DF-B9CC-F525E7214FB3Q36300051-564CD8E2-1F05-4FBF-BD14-701EDEC4F612Q36844830-0C79FC16-8DA0-42E2-ADE2-20F293B304C9Q36917265-F68DF1FF-ECA2-4B60-AEF0-983247747BC9Q37141290-9FBE02E8-FA58-4FE7-B99A-0E3B983F810BQ37369416-8CF78B8E-46CD-49B2-91B0-B0D9DFE03961Q37436125-16FA4C79-A23E-4B36-A757-44BA214CC2A2Q37481586-D45E05D3-112D-44BB-B1AE-76E87FD858EAQ37583967-88AA64F3-7ADC-4CF3-847A-C3E29ACAE2BBQ38789911-ACCC3DA6-197C-4843-A92E-BB34C09D9D45Q41890064-01577CEB-E2DE-4218-86B4-FFF6BD59F560Q44966103-F48CBA9C-AA8F-4C91-81C1-3E0B2755A5CEQ47841367-160982B7-1083-4E71-84B7-78D1E36AD035Q48559497-05547052-A159-4AF8-B267-84662E3DB0D2Q49870570-9B938521-87C0-4FBC-84BB-B757292AE930Q50610232-3B5F98BF-A453-4DAE-95FF-1EA61AA093B6Q54620133-A7B365B2-69C5-4BDA-A4B9-4164B00C4B54
P2860
Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Tobacco use in schizophrenia: ...... liva of patients and controls.
@en
Tobacco use in schizophrenia: ...... liva of patients and controls.
@nl
type
label
Tobacco use in schizophrenia: ...... liva of patients and controls.
@en
Tobacco use in schizophrenia: ...... liva of patients and controls.
@nl
prefLabel
Tobacco use in schizophrenia: ...... liva of patients and controls.
@en
Tobacco use in schizophrenia: ...... liva of patients and controls.
@nl
P1433
P1476
Tobacco use in schizophrenia: ...... liva of patients and controls.
@en
P2093
Henrik Nybäck
Jan-Erik Strand
P356
10.1016/J.EURPSY.2004.09.005
P407
P577
2005-01-01T00:00:00Z